Trinity College Dublin (TCD) is hosting the kick-off event of the PARADISE project this week from the 3rd to the 4th of April in Dublin. The PARADISE project (PersonAlisation of RelApse risk in autoimmune DISEase) aims to develop a personalised tool for predicting the risk of relapse of the disease so that medication dosages can be adjusted, reduced, and even stopped by gathering a wide range of partners from Europe as part of the ERA PerMed Joint translational call for proposals (2022) for “Prevention in personalised Medicine”.

The project is coordinated by Prof Mark Little, MD, from the Trinity Translational Medicine Institute and the ADAPT Center at Trinity College Dublin, one of the partners is the Catholic University of Croatia. Anto Čartolovni, head of the Digital healthcare ethics laboratory (Digit-HeaL) and Assistant Professor at the Faculty of Medicine of the Catholic University of Croatia leads activities within WP5 – Transparent and Explainable Prediction. At the meeting in Dublin, Assistant Professor Čartolovni presented the work plan, goals and activities that will be realised in the next 36 months of the project. Other partners are from KTH Royal Institute of Technology (Sweden), the University of Freiburg (Germany), Firalis S. A. (France), The European Institute for Innovation through Health Data I-HD (Belgium), Vasculitis Ireland Awareness (Ireland), Bellvitge Biomedical Research Institute (Spain).

ERA PerMed is an initiative that supports partners from 26 countries. Through transnational initiatives, it encourages research activities and innovations as well as research on integrating personalised medicine into clinical practice, giving importance to the ethical, legal and social implications of such research. The Republic of Croatia’s Ministry of Science and Education is a partner of the joint transnational call for innovative, collaborative research projects in personalised medicine; thus, the primary funder of Croatian partners. At the end of March 2023, the Minister of Science and Education, Prof Radovan Fuchs, and the rector of the Catholic University of Croatia, Prof Željko Tanjić, signed an agreement on financing the research activities within the PARADISE project.

For more information about the ERA PerMed call and the PARADISE project (p. 18) in the ERA Per Med Newsletter, please click on the following link.